4//SEC Filing
Chipman Christopher Michael 4
Accession 0001493152-23-002831
CIK 0001708331other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 8:30 PM ET
Size
5.3 KB
Accession
0001493152-23-002831
Insider Transaction Report
Form 4
Chipman Christopher Michael
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-25+112,000→ 112,000 totalExercise: $0.79Exp: 2033-01-25→ Common Stock (112,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments commencing on January 25, 2024.
Documents
Issuer
Virpax Pharmaceuticals, Inc.
CIK 0001708331
Entity typeother
Related Parties
1- filerCIK 0001354941
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 8:30 PM ET
- Size
- 5.3 KB